复发性肌肉肉瘤:欧洲儿科软组织肉瘤研究小组 (EpSSG) 的治疗建议
A S Defachelles1, W B Breunis2, M Casanova3
1Department of Pediatric and AYA Oncology, Oscar Lambret Center, Lille, France. as-defachelles@o-lambret.fr.
British journal of cancer
|September 5, 2025
概括
复发性肌肉肉瘤 (RMS) 的结果不好. 这项研究提供了欧洲专家对包括化疗和局部控制在内的多学科治疗的建议,以改善患者的生存率.
科学领域:
- 儿童瘤学
- 癌症研究
- 临床实践指南
背景情况:
- 肌肉瘤 (RMS) 复发影响了很大一部分患者,预后不佳,治疗选择有限.
- 治疗复发性RMS是复杂的,需要基于证据的最新策略来改善患者的治疗结果.
- 目前对复发性RMS的治疗模式需要改进,以解决高次复发率的问题.
研究的目的:
- 制定明确,实用和标准化的欧洲建议,用于治疗复发性肌肉肉瘤.
- 为临床医生提供一个框架,以便在治疗复发性RMS的儿童和青少年患者时做出明智的决定.
- 巩固专家的共识,以优化复发性RMS的化疗和局部控制策略.
主要方法:
- 由欧洲儿科软组织肉瘤研究小组的儿科和青少年肉瘤专家共同制定建议.
- 综合文献审查,优先考虑临床试验数据和强有力的回顾性报告.
- 建立共识,制定基于证据的管理准则.
主要成果:
- 在欧洲开发一种标准化方法来治疗复发性肌肉肉瘤.
- 建议强调将化疗与局部控制措施结合在一起的多学科策略.
- 这些指导方针旨在加强临床决策并改善复发性RMS患者的治疗结果.
结论:
- 标准化治疗方案对于改善复发性肌肉肉瘤的结果至关重要.
- 综合系统治疗和局部治疗的多学科护理对于复发性疾病至关重要.
- 这些欧洲建议为治疗儿童和青少年RMS患者的临床医生提供了重要资源.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


